
For AstraZeneca, a global biopharmaceutical leader with medicines reaching millions of patients every day, quality doesn’t end when a pill leaves the plant. Every link in the supply chain — from manufacturing to warehousing to final delivery — has to operate under the same strict regulatory standards.
But AstraZeneca’s audits kept uncovering the same problem:
The cracks were subtle but dangerous. A missed temperature log here, an incomplete SOP record there — each gap introduced regulatory risk, financial loss, and potential impact on patient safety.
In one high-stakes audit, AstraZeneca discovered a warehouse partner’s compliance packet was missing timestamped records for a critical storage step. The work had been done — but the proof wasn’t there.
The audit flagged the site as non-compliant. The remediation effort took weeks and cost the company valuable time and money. More importantly, it exposed a vulnerability that could easily repeat itself.
The realization was clear: AstraZeneca needed a better way to guarantee supplier compliance, without relying on paper or goodwill.
AstraZeneca turned to Atheer to close the compliance gap and bring real-time visibility into supplier operations. Here’s how they did it:
Instead of reacting to missing paperwork, AstraZeneca built compliance into the process itself.
The impact was immediate and measurable:

And perhaps most importantly: AstraZeneca regained confidence that their partners were meeting the same high bar of compliance they demand internally.
